Royalty Pharma Plc (RPRX) EVP & CFO Terrance P. Coyne Sold $4.5 million of Shares
- By insider
EVP & CFO of Royalty Pharma Plc (30-Year Financial, Insider Trades) Terrance P. Coyne (insider trades) sold 100,000 shares of RPRX on 03/03/2021 at an average price of $44.78 a share. The total sale was $4.5 million.
Royalty Pharma Plc has a market cap of $25.83 billion; its shares were traded at around $42.540000 with a P/E ratio of 34.27 and P/S ratio of 7.41. The dividend yield of Royalty Pharma Plc stocks is 1.12%.
CFO Recent Trades:
EVP & CFO Terrance P. Coyne sold 100,000 shares of RPRX stock on 03/03/2021 at the average price of $44.78. The price of the stock has decreased by 5% since.
EVP & CFO Terrance P. Coyne sold 100,000 shares of RPRX stock on 03/02/2021 at the average price of $46.94. The price of the stock has decreased by 9.37% since.
Directors and Officers Recent Trades:
Director Henry A Fernandez bought 25,700 shares of RPRX stock on 02/25/2021 at the average price of $46.83. The price of the stock has decreased by 9.16% since.
EVP, Investments & GC George W. Lloyd sold 125,000 shares of RPRX stock on 03/02/2021 at the average price of $46.94. The price of the stock has decreased by 9.37% since.
EVP, Research & Investments James F. Reddoch sold 100,000 shares of RPRX stock on 03/02/2021 at the average price of $46.92. The price of the stock has decreased by 9.34% since.
For the complete insider trading history of RPRX, click here
.This article first appeared on GuruFocus.
